Einführung
Diese Seite bietet eine umfassende Analyse des bekannten Insiderhandels von Anthony Welters. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Es ist für Insider illegal, auf der Grundlage bestimmter, nicht öffentlicher Informationen mit ihren Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden. Trotz dieser Einschränkungen deuten akademische Untersuchungen darauf hin, dass Insider im Allgemeinen dazu neigen, den Markt in ihren eigenen Unternehmen zu übertreffen.
Durchschnittliche Handelsrentabilität
Die durchschnittliche Handelsrentabilität ist die durchschnittliche Rendite aller offenen Marktkäufe, die der Insider in den letzten drei Jahren getätigt hat. Um dies zu berechnen, untersuchen wir jeden ungeplanten Kauf, den der Insider auf dem offenen Markt getätigt hat, mit Ausnahme aller Geschäfte, die als Teil eines 10b5-1-Handelsplans gekennzeichnet waren. Anschließend berechnen wir die durchschnittliche Performance dieser Geschäfte über 3, 6 und 12 Monate, wobei wir für jeden dieser Zeiträume den Durchschnitt bilden, um eine endgültige Performance-Kennzahl für jedes Geschäft zu erhalten. Schließlich berechnen wir den Durchschnitt aller Performance-Metriken, um eine Performance-Metrik für den Insider zu ermitteln. Diese Liste enthält nur Insider, die in den letzten zwei Jahren mindestens drei Geschäfte getätigt haben.
Wenn die Handelsrentabilität dieses Insiders "N/A" ist, hat er entweder in den letzten drei Jahren keine Käufe auf dem freien Markt getätigt, oder die von ihm getätigten Geschäfte sind zu kurz her, um eine zuverlässige Performance-Kennzahl zu berechnen.
Aktualisierungshäufigkeit: Täglich
Unternehmen mit gemeldeten Insiderpositionen
Aus den SEC-Filings geht hervor, dass Anthony Welters Beteiligungen an den folgenden Unternehmen gemeldet oder mit ihnen gehandelt hat:
| Wertpapier | Titel | Letzte gemeldete Beteiligungen |
|---|---|---|
| US:GILD / Gilead Sciences, Inc. | Director | 12.894 |
| US:CG / The Carlyle Group Inc. | Director | 47.849 |
| US:L / Loews Corporation | Director | 9.845 |
| US:BCR / C. R. Bard, Inc. - Corporate Bond/Note | Director | 0 |
| US:WST / West Pharmaceutical Services, Inc. | Director | 62.142 |
| US:UNH / UnitedHealth Group Incorporated | EVP, UnitedHealth Group | 119.909 |
So interpretieren Sie die Diagramme
Die folgenden Diagramme zeigen die Wertentwicklung von Wertpapieren nach jedem offenen, nicht geplanten Handel von Anthony Welters. Nicht geplante Geschäfte sind Geschäfte, die nicht im Rahmen eines 10b5-1-Handelsplans getätigt wurden. Die Aktienperformance wird als kumulative prozentuale Veränderung des Aktienkurses dargestellt. Wenn beispielsweise am 1. Januar 2019 ein Insiderhandel getätigt wurde, zeigt das Diagramm die tägliche prozentuale Veränderung des Wertpapiers bis zum heutigen Tag. Wenn der Aktienkurs in dieser Zeit von $10 auf $15 gestiegen ist, beträgt die kumulative prozentuale Veränderung des Aktienkurses 50 %. Eine Kursveränderung von $10 auf $20 würde 100% betragen und eine Kursveränderung von $10 auf $5 wäre -50%.
Letztendlich versuchen wir festzustellen, wie eng die Geschäfte des Insiders mit den (positiven oder negativen) Überschussrenditen des Aktienkurses korrelieren, um zu sehen, ob der Insider seine Geschäfte zeitlich so abstimmt, dass er von Insiderinformationen profitiert. Stellen Sie sich die Situation vor, dass ein Insider dies tun würde. In dieser Situation würden wir entweder (a) positive Renditen nach Käufen oder (b) negative Renditen nach Verkäufen erwarten. Im Falle von (a) würde das KAUF-Diagramm eine Reihe von aufwärts gerichteten Kurven zeigen, die auf positive Renditen nach jeder Kauftransaktion hinweisen. Im Falle von (b) würde das VERKAUFS-Diagramm eine Reihe von abwärts gerichteten Kurven zeigen, die auf negative Renditen nach jeder Verkaufstransaktion hinweisen.
Dies allein reicht jedoch nicht aus, um Schlussfolgerungen zu ziehen. Wenn sich der Aktienkurs des Unternehmens beispielsweise über viele Jahre hinweg in einem nicht-zyklischen Aufwärtstrend befand, dann würden wir erwarten, dass alle Nach-Kauf-Kurven aufwärts gerichtet sind. Ebenso würden nicht-zyklische Rückgänge über viele Jahre hinweg zu abwärts geneigten Nachhandelsdiagrammen führen. Keines dieser Diagramme würde auf Insiderhandel hindeuten.
Der stärkste Indikator wäre eine Situation, in der der Aktienkurs extrem zyklisch war und es sowohl positive Signale im KAUF-Chart als auch negative im VERKAUF-Chart gab. Diese Situation würde stark auf einen Insider hindeuten, der das Timing von Geschäften zu seinem finanziellen Vorteil nutzt.
Insiderkäufe CG / The Carlyle Group Inc. - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in CG / The Carlyle Group Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Max |
Preis bei Max |
Max Gewinn ($) |
Max Rendite (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-12-02 | CG | WELTERS ANTHONY | 25.000 | 17,7714 | 25.000 | 17,7714 | 444.285 | 139 | 17.7000 | -1.785 | -0,40 |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Insiderverkäufe CG / The Carlyle Group Inc. - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in CG / The Carlyle Group Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel und die Ergebnisse sind theoretisch.
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Ticker | Insider | Berichtete Aktien |
Berichteter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden ($) |
Max. Verlust Vermieden (%) |
|---|---|---|---|---|---|---|---|
| Für diese Insider- und Wertpapierkombination sind keine ungeplanten Open-Market-Trades bekannt |
Angepasster Preis ist der an den Split angepasste Preis. Angepasste Aktien ist die an den Split angepasste Anzahl der Aktien.
Geschichte des Insiderhandels
Diese Tabelle zeigt die vollständige Liste der von Anthony Welters getätigten Insidergeschäfte, die der Securities Exchange Commission (SEC) gemeldet wurden.
| Datum der Einreichung | Tran Datum | Form | Ticker | Wertpapier | Code | Aktien | Verbleibende Aktien | Prozent Änderung |
Aktie Preis |
Tran Wert |
Verbleibender Wert |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 |
|
4 | GILD |
GILEAD SCIENCES, INC.
Common Stock |
A - Award | 1.146 | 12.894 | 9,75 | ||||
| 2026-05-01 |
|
4 | CG |
Carlyle Group Inc.
Common Stock |
A - Award | 4.450 | 47.849 | 10,25 | ||||
| 2025-11-25 |
|
4 | CG |
Carlyle Group Inc.
Common Stock |
G - Gift | -1.200 | 43.399 | -2,69 | ||||
| 2025-11-25 |
|
4 | CG |
Carlyle Group Inc.
Common Stock |
G - Gift | -11.706 | 44.599 | -20,79 | ||||
| 2025-05-08 |
|
4 | GILD |
GILEAD SCIENCES, INC.
Common Stock |
A - Award | 1.516 | 11.748 | 14,82 | ||||
| 2025-05-02 |
|
4 | CG |
Carlyle Group Inc.
Common Stock |
A - Award | 5.235 | 56.305 | 10,25 | ||||
| 2025-03-04 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | -1.197 | 9.845 | -10,84 | 86,87 | -103.983 | 855.235 |
| 2025-03-04 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | -1.053 | 11.042 | -8,71 | 86,89 | -91.495 | 959.439 |
| 2025-03-04 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2.250 | 12.095 | 22,85 | 40,61 | 91.372 | 491.178 |
| 2024-12-03 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | -1.146 | 9.845 | -10,43 | 86,81 | -99.484 | 854.644 |
| 2024-12-03 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | -1.104 | 10.991 | -9,13 | 86,80 | -95.827 | 954.019 |
| 2024-12-03 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2.250 | 12.095 | 22,85 | 42,52 | 95.670 | 514.279 |
| 2024-11-29 |
|
4 | CG |
Carlyle Group Inc.
Common Stock |
G - Gift | -13.280 | 51.070 | -20,64 | ||||
| 2024-09-04 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | -1.088 | 9.845 | -9,95 | 81,41 | -88.574 | 801.481 |
| 2024-09-04 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | -1.162 | 10.933 | -9,61 | 81,42 | -94.610 | 890.165 |
| 2024-09-04 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2.250 | 12.095 | 22,85 | 41,98 | 94.455 | 507.748 |
| 2024-06-04 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | -963 | 9.845 | -8,91 | 75,80 | -72.995 | 746.251 |
| 2024-06-04 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | -1.287 | 10.808 | -10,64 | 76,59 | -98.571 | 827.785 |
| 2024-06-04 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2.250 | 12.095 | 22,85 | 43,83 | 98.618 | 530.124 |
| 2024-05-09 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1.706 | 9.845 | 20,96 | ||||
| 2024-05-09 |
|
4 | GILD |
GILEAD SCIENCES, INC.
Common Stock |
A - Award | 2.310 | 10.232 | 29,16 | ||||
| 2024-05-03 |
|
4 | CG |
Carlyle Group Inc.
Common Stock |
A - Award | 5.004 | 64.350 | 8,43 | ||||
| 2024-03-04 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | -951 | 8.139 | -10,46 | 75,01 | -71.335 | 610.506 |
| 2024-03-04 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | -1.299 | 9.090 | -12,50 | 75,07 | -97.516 | 682.386 |
| 2024-03-04 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2.250 | 10.389 | 27,64 | 43,37 | 97.582 | 450.571 |
| 2023-12-04 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | -715 | 8.139 | -8,08 | 70,16 | -50.164 | 571.032 |
| 2023-12-04 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | -1.535 | 8.854 | -14,78 | 70,08 | -107.573 | 620.488 |
| 2023-12-04 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2.250 | 10.389 | 27,64 | 47,84 | 107.640 | 497.010 |
| 2023-05-10 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1.567 | 8.139 | 23,84 | ||||
| 2023-05-04 |
|
4 | GILD |
GILEAD SCIENCES, INC.
Common Stock |
A - Award | 1.887 | 7.922 | 31,27 | ||||
| 2023-05-03 |
|
4 | CG |
Carlyle Group Inc.
Common Stock |
A - Award | 6.238 | 59.346 | 11,75 | ||||
| 2022-12-22 |
|
4 | L |
LOEWS CORP
Common Stock |
G - Gift | -877 | 6.572 | -11,77 | ||||
| 2022-05-11 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
M - Exercise | -1.725 | 0 | -100,00 | ||||
| 2022-05-11 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1.725 | 7.449 | 30,14 | ||||
| 2022-05-11 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 1.567 | 1.567 | |||||
| 2022-05-06 |
|
4 | GILD |
GILEAD SCIENCES, INC.
Non-qualified Stock Option (Right to Buy) |
A - Award | 15.851 | 15.851 | |||||
| 2022-05-06 |
|
4 | GILD |
GILEAD SCIENCES, INC.
Common Stock |
A - Award | 2.444 | 6.035 | 68,06 | ||||
| 2022-05-03 |
|
4 | GILD |
GILEAD SCIENCES, INC.
Restricted Stock Unit |
M - Exercise | -2.223 | 0 | -100,00 | ||||
| 2022-05-03 |
|
4 | GILD |
GILEAD SCIENCES, INC.
Common Stock |
M - Exercise | 2.223 | 3.591 | 162,50 | ||||
| 2022-05-02 |
|
4 | CG |
Carlyle Group Inc.
Common Stock |
A - Award | 5.236 | 53.108 | 10,94 | ||||
| 2022-01-04 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
M - Exercise | -1.959 | 0 | -100,00 | ||||
| 2022-01-04 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1.959 | 5.724 | 52,03 | ||||
| 2021-12-16 |
|
4 | L |
LOEWS CORP
Common Stock |
G - Gift | -1.755 | 3.765 | -31,79 | ||||
| 2021-12-13 |
|
4 | L |
LOEWS CORP
Common Stock |
G - Gift | -5.285 | 5.520 | -48,91 | ||||
| 2021-12-10 |
|
4 | CG |
Carlyle Group Inc.
Common Stock |
G - Gift | -10.951 | 47.872 | -18,62 | ||||
| 2021-10-26 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
M - Exercise | -1.368 | 2.223 | -38,10 | ||||
| 2021-10-26 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 1.368 | 1.368 | |||||
| 2021-09-03 |
|
4 | CG |
Carlyle Group Inc.
Common Stock |
G - Gift | -1.530 | 58.823 | -2,54 | ||||
| 2021-05-14 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 14.665 | 14.665 | |||||
| 2021-05-14 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
A - Award | 2.223 | 3.591 | 162,50 | ||||
| 2021-05-12 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
M - Exercise | -3.292 | 0 | -100,00 | ||||
| 2021-05-12 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 3.292 | 10.805 | 43,82 | ||||
| 2021-05-12 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 1.725 | 1.725 | |||||
| 2021-05-03 |
|
4 | CG |
Carlyle Group Inc.
Common Stock |
A - Award | 3.985 | 60.353 | 7,07 | ||||
| 2020-10-26 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 7.718 | 7.718 | |||||
| 2020-10-26 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
A - Award | 1.368 | 1.368 | |||||
| 2020-05-14 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
M - Exercise | -1.979 | 0 | -100,00 | ||||
| 2020-05-14 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1.979 | 7.513 | 35,76 | ||||
| 2020-05-14 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3.292 | 3.292 | |||||
| 2020-05-05 |
|
4 | CG |
Carlyle Group Inc.
Common Stock |
A - Award | 5.411 | 56.368 | 10,62 | ||||
| 2019-05-14 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 1.979 | 1.979 | |||||
| 2019-05-03 |
|
4 | CG |
Carlyle Group L.P.
Common Units |
A - Award | 5.854 | 50.957 | 12,98 | ||||
| 2018-12-13 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 1.960 | 0,14 | ||||
| 2018-12-13 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2.150 | 0,14 | ||||
| 2018-09-13 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 2 | 1.957 | 0,12 | ||||
| 2018-09-13 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2.147 | 0,13 | ||||
| 2018-06-13 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 2 | 1.954 | 0,13 | ||||
| 2018-06-13 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2.145 | 0,13 | ||||
| 2018-05-09 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 1.952 | 1.952 | |||||
| 2018-05-03 |
|
4 | CG |
Carlyle Group L.P.
Common Units |
A - Award | 5.826 | 45.103 | 14,83 | ||||
| 2018-03-15 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2.142 | 0,12 | ||||
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Share Equivalent Units |
D - Sale to Issuer | -17.808 | 0 | -100,00 | ||||
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
D - Sale to Issuer | -20.597 | 0 | -100,00 | ||||
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 83 | 20.597 | 0,41 | 331,24 | 27.632 | 6.822.517 | |
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
D - Sale to Issuer | -4.520 | 0 | -100,00 | ||||
| 2017-12-14 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2.139 | 0,13 | ||||
| 2017-12-05 |
|
4 | BCR |
BARD C R INC /NJ/
Share Equivalent Units |
A - Award | 245 | 17.808 | 1,39 | ||||
| 2017-12-05 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 298 | 4.520 | 7,06 | ||||
| 2017-09-14 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2.137 | 0,13 | ||||
| 2017-07-05 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 169 | 20.481 | 0,83 | 316,39 | 53.502 | 6.479.863 | |
| 2017-06-15 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2.134 | 0,13 | ||||
| 2017-06-01 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | -1.200 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | -1.200 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | -662 | 4.222 | -13,55 | 309,24 | -204.720 | 1.305.632 | |
| 2017-06-01 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 1.200 | 4.884 | 32,57 | 81,70 | 98.034 | 398.998 | |
| 2017-06-01 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 1.200 | 3.684 | 48,31 | 88,76 | 106.506 | 326.973 | |
| 2017-05-26 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | -1.200 | 0 | -100,00 | ||||
| 2017-05-26 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | -325 | 2.484 | -11,57 | 308,35 | -100.214 | 765.941 | |
| 2017-05-26 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 1.200 | 2.809 | 74,58 | 83,47 | 100.168 | 234.476 | |
| 2017-05-11 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
M - Exercise | -2.534 | 0 | -100,00 | ||||
| 2017-05-11 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 2.534 | 5.534 | 84,47 | ||||
| 2017-05-11 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 2.131 | 2.131 | |||||
| 2017-05-03 |
|
4 | CG |
Carlyle Group L.P.
Common Units |
A - Award | 5.634 | 39.277 | 16,75 | ||||
| 2017-03-15 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2.534 | 0,13 | ||||
| 2017-01-05 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 228 | 20.272 | 1,13 | 227,47 | 51.749 | 4.611.320 | |
| 2017-01-05 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
G - Gift | -767 | 1.609 | -32,28 | ||||
| 2016-12-15 |
|
4 | BCR |
BARD C R INC /NJ/
Share Equivalent Units |
A - Award | 375 | 17.563 | 2,18 | ||||
| 2016-12-15 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 468 | 2.376 | 24,53 | ||||
| 2016-12-15 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2.531 | 0,13 | ||||
| 2016-09-14 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 4 | 2.528 | 0,15 | ||||
| 2016-07-06 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 213 | 19.998 | 1,08 | 234,75 | 50.100 | 4.694.427 | |
| 2016-06-16 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 4 | 2.524 | 0,16 | ||||
| 2016-05-11 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 2.520 | 2.520 | |||||
| 2016-05-03 |
|
4 | CG |
Carlyle Group L.P.
Common Units |
A - Award | 5.974 | 33.643 | 21,59 | ||||
| 2016-04-04 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 290 | 62.142 | 0,47 | 68,91 | 20.000 | 4.282.227 | |
| 2016-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | -1.200 | 0 | -100,00 | ||||
| 2016-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | -1.784 | 1.908 | -48,32 | 187,47 | -334.453 | 357.700 | |
| 2016-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 1.200 | 3.692 | 48,15 | 73,99 | 88.788 | 273.171 | |
| 2016-01-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 287 | 61.721 | 0,47 | 61,07 | 17.500 | 3.769.316 | |
| 2016-01-06 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 301 | 19.737 | 1,55 | 183,90 | 55.400 | 3.629.552 | |
| 2016-01-05 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2.250 | 2.250 | |||||
| 2015-12-11 |
|
4 | BCR |
BARD C R INC /NJ/
Share Equivalent Units |
A - Award | 442 | 17.188 | 2,64 | ||||
| 2015-12-11 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 536 | 2.492 | 27,40 | ||||
| 2015-12-04 |
|
4 | L |
LOEWS CORP
Common Stock |
P - Purchase | 3.000 | 3.000 | 38,31 | 114.930 | 114.930 | ||
| 2015-12-03 |
|
4 | CG |
Carlyle Group L.P.
Common Units |
P - Purchase | 25.000 | 27.669 | 936,68 | 17,77 | 444.285 | 491.717 | |
| 2015-11-03 |
|
4 | CG |
Carlyle Group L.P.
Common Units |
A - Award | 2.669 | 2.669 | |||||
| 2015-10-05 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 319 | 61.254 | 0,52 | 54,83 | 17.500 | 3.358.559 | |
| 2015-10-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2.250 | 2.250 | |||||
| 2015-07-02 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 263 | 19.387 | 1,38 | 172,77 | 45.501 | 3.349.423 | |
| 2015-07-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 301 | 60.886 | 0,50 | 58,13 | 17.500 | 3.539.281 | |
| 2015-07-01 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2.250 | 2.250 | |||||
| 2015-05-07 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 2.448 | 43.536 | 5,96 | ||||
| 2015-04-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2.250 | 2.250 | |||||
| 2015-04-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 293 | 60.327 | 0,49 | 59,66 | 17.500 | 3.599.131 | |
| 2015-02-11 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | -1.563 | 1.956 | -44,42 | 169,02 | -264.177 | 330.602 | |
| 2015-02-09 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 325 | 60.034 | 0,54 | ||||
| 2015-01-06 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 282 | 19.074 | 1,50 | 167,48 | 47.151 | 3.194.542 | |
| 2015-01-05 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2.250 | 2.250 | |||||
| 2015-01-05 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 325 | 59.962 | 0,55 | ||||
| 2014-12-12 |
|
4 | BCR |
BARD C R INC /NJ/
Share Equivalent Units |
A - Award | 413 | 16.746 | 2,53 | ||||
| 2014-12-12 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 605 | 3.519 | 20,76 | ||||
| 2014-10-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 389 | 59.580 | 0,66 | ||||
| 2014-10-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2.250 | 2.250 | |||||
| 2014-07-02 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 312 | 18.740 | 1,69 | 145,82 | 45.500 | 2.732.649 | |
| 2014-07-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 416 | 59.045 | 0,71 | 42,02 | 17.500 | 2.481.079 | |
| 2014-07-01 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2.250 | 2.250 | |||||
| 2014-05-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 3.016 | 40.763 | 7,99 | ||||
| 2014-04-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 406 | 58.480 | 0,70 | ||||
| 2014-04-01 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2.250 | 2.250 | |||||
| 2014-01-27 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 357 | 57.959 | 0,62 | ||||
| 2014-01-06 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 370 | 18.371 | 2,06 | 131,83 | 48.800 | 2.421.883 | |
| 2014-01-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2.250 | 2.250 | |||||
| 2013-12-13 |
|
4 | BCR |
BARD C R INC /NJ/
Share Equivalent Units |
A - Award | 512 | 16.333 | 3,24 | ||||
| 2013-12-13 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 767 | 2.914 | 35,72 | ||||
| 2013-08-14 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy) |
M - Exercise | -3.200 | 0 | -100,00 | 28,25 | -90.400 | ||
| 2013-08-14 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy) |
M - Exercise | -6.400 | 0 | -100,00 | 19,36 | -123.936 | ||
| 2013-08-14 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy) |
M - Exercise | -6.400 | 0 | -100,00 | 36,10 | -231.040 | ||
| 2013-08-14 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy) |
M - Exercise | -3.200 | 0 | -100,00 | 26,37 | -84.384 | ||
| 2013-08-14 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | -19.200 | 18.762 | -50,58 | 78,43 | -1.505.875 | 1.471.551 | |
| 2013-08-14 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | 3.200 | 37.962 | 9,21 | 26,37 | 84.384 | 1.001.068 | |
| 2013-08-14 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | 3.200 | 34.762 | 10,14 | 28,25 | 90.400 | 982.037 | |
| 2013-08-14 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | 6.400 | 31.562 | 25,43 | 19,36 | 123.936 | 611.205 | |
| 2013-08-14 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | 6.400 | 25.162 | 34,11 | 36,10 | 231.040 | 908.362 | |
| 2013-07-30 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | -1.200 | 0 | -100,00 | ||||
| 2013-07-30 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | -1.200 | 0 | -100,00 | ||||
| 2013-07-30 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | -1.200 | 0 | -100,00 | ||||
| 2013-07-30 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | -1.200 | 0 | -100,00 | ||||
| 2013-07-30 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | -5.600 | 2.147 | -72,29 | 113,12 | -633.474 | 242.869 | |
| 2013-07-30 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 1.200 | 7.747 | 18,33 | 54,96 | 65.958 | 425.814 | |
| 2013-07-30 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 1.200 | 6.547 | 22,44 | 57,01 | 68.412 | 373.244 | |
| 2013-07-30 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 1.200 | 5.347 | 28,94 | 63,43 | 76.116 | 339.160 | |
| 2013-07-30 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 1.200 | 4.147 | 40,72 | 66,80 | 80.154 | 276.999 | |
| 2013-07-02 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 436 | 17.941 | 2,49 | 108,17 | 47.150 | 1.940.664 | |
| 2013-05-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 2.003 | 18.719 | 11,98 | ||||
| 2013-02-08 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
G - Gift | -800 | 2.947 | -21,35 | ||||
| 2013-02-08 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | -1.200 | 0 | -100,00 | ||||
| 2013-02-08 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | -1.200 | 0 | -100,00 | ||||
| 2013-02-08 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | -2.400 | 3.747 | -39,04 | 101,48 | -243.557 | 380.253 | |
| 2013-02-08 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 1.200 | 6.147 | 24,26 | 35,71 | 42.852 | 219.509 | |
| 2013-02-08 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 1.200 | 4.947 | 32,03 | 39,36 | 47.235 | 194.726 | |
| 2013-01-04 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 395 | 17.436 | 2,32 | 101,83 | 40.200 | 1.775.557 | |
| 2012-12-14 |
|
4 | BCR |
BARD C R INC /NJ/
Share Equivalent Units |
A - Award | 715 | 15.821 | 4,73 | ||||
| 2012-12-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 584 | 3.747 | 18,46 | ||||
| 2012-12-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
G - Gift | -1.600 | 3.163 | -33,59 | ||||
| 2012-10-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 236 | 28.394 | 0,84 | ||||
| 2012-08-14 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
G - Gift | -600 | 16.568 | -3,49 | ||||
| 2012-07-03 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 437 | 16.971 | 2,64 | 107,83 | 47.150 | 1.830.034 | |
| 2012-07-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 229 | 28.055 | 0,82 | ||||
| 2012-06-07 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
F - Taxes | -7.211 | 119.909 | -5,67 | 56,04 | -404.104 | 6.719.691 | |
| 2012-05-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 2.459 | 17.120 | 16,77 | ||||
| 2012-04-24 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Stock Appreciation Right |
M - Exercise | -38.012 | 38.012 | -50,00 | ||||
| 2012-04-24 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Stock Appreciation Right |
M - Exercise | -28.280 | 28.280 | -50,00 | ||||
| 2012-04-24 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Stock Appreciation Right |
M - Exercise | -23.639 | 21.212 | -52,71 | ||||
| 2012-04-24 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -70.000 | 200.000 | -25,93 | ||||
| 2012-04-24 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
S - Sale | -90.571 | 127.120 | -41,61 | 59,07 | -5.349.775 | 7.508.613 | |
| 2012-04-24 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
F - Taxes | -28.225 | 217.691 | -11,48 | 59,51 | -1.679.670 | 12.954.782 | |
| 2012-04-24 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
M - Exercise | 38.012 | 245.916 | 18,28 | 33,00 | 1.254.396 | 8.115.223 | |
| 2012-04-24 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
F - Taxes | -20.103 | 207.904 | -8,82 | 59,51 | -1.196.330 | 12.372.357 | |
| 2012-04-24 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
M - Exercise | 28.280 | 228.007 | 14,16 | 29,74 | 841.047 | 6.780.923 | |
| 2012-04-24 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
F - Taxes | -17.769 | 199.727 | -8,17 | 59,51 | -1.057.433 | 11.885.744 | |
| 2012-04-24 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
M - Exercise | 23.639 | 217.496 | 12,19 | 33,94 | 802.308 | 7.381.809 | |
| 2012-04-24 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
M - Exercise | 70.000 | 193.857 | 56,52 | 42,86 | 3.000.550 | 8.309.673 | |
| 2012-04-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 316 | 27.714 | 1,15 | ||||
| 2012-03-20 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
A - Award | 216 | 123.857 | 0,17 | ||||
| 2012-03-09 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
S - Sale | -30.000 | 123.641 | -19,53 | 55,54 | -1.666.266 | 6.867.294 | |
| 2012-02-24 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy) |
M - Exercise | -9.000 | 0 | -100,00 | 13,99 | -125.932 | ||
| 2012-02-24 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | -9.000 | 14.610 | -38,12 | 42,61 | -383.531 | 622.611 | |
| 2012-02-24 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | 9.000 | 23.610 | 61,60 | 13,99 | 125.932 | 330.367 | |
| 2012-02-14 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
S - Sale | -76.000 | 153.641 | -33,10 | 53,58 | -4.071.753 | 8.231.425 | |
| 2012-02-10 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
F - Taxes | -3.088 | 229.641 | -1,33 | 53,06 | -163.849 | 12.184.752 | |
| 2012-02-10 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
F - Taxes | -5.862 | 232.729 | -2,46 | 53,06 | -311.038 | 12.348.601 | |
| 2012-02-09 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
F - Taxes | -64.924 | 238.591 | -21,39 | 52,03 | -3.377.996 | 12.413.890 | |
| 2012-02-09 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
A - Award | 153.846 | 303.515 | 102,79 | ||||
| 2012-02-09 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
A - Award | 38.440 | 149.669 | 34,56 | 52,03 | 2.000.033 | 7.787.279 | |
| 2012-02-07 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | -2.400 | 0 | -100,00 | ||||
| 2012-02-07 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | -1.200 | 0 | -100,00 | ||||
| 2012-02-07 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | -1.200 | 0 | -100,00 | ||||
| 2012-02-07 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | -4.800 | 4.763 | -50,19 | 93,23 | -447.493 | 444.044 | |
| 2012-02-07 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 1.200 | 9.563 | 14,35 | 26,01 | 31.215 | 248.758 | |
| 2012-02-07 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 1.200 | 8.363 | 16,75 | 28,04 | 33.645 | 234.478 | |
| 2012-02-07 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 2.400 | 7.163 | 50,39 | 25,71 | 61.704 | 184.161 | |
| 2012-02-07 |
|
4 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
F - Taxes | -2.957 | 111.229 | -2,59 | 51,31 | -151.724 | 5.707.161 | |
| 2012-01-04 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 289 | 16.470 | 1,79 | 86,37 | 25.000 | 1.422.491 | |
| 2012-01-04 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 201 | 16.180 | 1,26 | 85,50 | 17.200 | 1.383.415 | |
| 2012-01-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 435 | 27.278 | 1,62 | 37,93 | 16.500 | 1.034.666 | |
| 2010-07-06 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 164 | 14.678 | 1,13 | 76,29 | 12.500 | 1.119.769 | |
| 2010-07-01 |
|
4 | BCR |
BARD C R INC /NJ/
Phantom Stock Units |
A - Award | 137 | 14.514 | 0,95 | 77,53 | 10.600 | 1.125.267 | |
| 2007-09-21 | 3 | UNH |
UNITEDHEALTH GROUP INC
Common Stock |
3.453 | ||||||||
| 2004-07-15 |
|
4 | bcr |
BARD C R INC /NJ/
Option (Right to Buy) |
A - Award | 600 | 600 |
